These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10384392)

  • 1. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects.
    Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
    J Inherit Metab Dis; 1999 May; 22(3):302-6. PubMed ID: 10384392
    [No Abstract]   [Full Text] [Related]  

  • 2. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
    Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
    Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of normal acylcarnitine levels in a healthy pediatric population as a diagnostic tool in inherited errors of mitochondrial fatty acid beta-oxidation].
    Osorio JH; Pourfarzam M
    An Pediatr (Barc); 2007 Dec; 67(6):548-52. PubMed ID: 18053519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of plasma/serum acylcarnitines using tandem mass spectrometry.
    Lepage N; Aucoin S
    Methods Mol Biol; 2010; 603():9-25. PubMed ID: 20077055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid diagnosis of organic acidemias and fatty-acid oxidation defects by quantitative electrospray tandem-MS acyl-carnitine analysis in plasma.
    Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
    Adv Exp Med Biol; 1999; 466():327-37. PubMed ID: 10709660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects.
    Ventura FV; Costa CG; Struys EA; Ruiter J; Allers P; Ijlst L; Tavares de Almeida I; Duran M; Jakobs C; Wanders RJ
    Clin Chim Acta; 1999 Mar; 281(1-2):1-17. PubMed ID: 10217622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of inborn errors of metabolism by acylcarnitine profiling in blood using tandem mass spectrometry.
    Vianey-Saban C; Guffon N; Delolne F; Guibaud P; Mathieu M; Divry P
    J Inherit Metab Dis; 1997 Jul; 20(3):411-4. PubMed ID: 9266369
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination.
    Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Tajima T; Sakura N; Yamaguchi S; Takayanagi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):63-72. PubMed ID: 12828998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry.
    Han L; Han F; Ye J; Qiu W; Zhang H; Gao X; Wang Y; Ji W; Gu X
    J Clin Lab Anal; 2015 Mar; 29(2):162-8. PubMed ID: 24797655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of plasma acylcarnitines using tandem mass spectrometry. Application to the diagnosis of metabolism hereditary diseases].
    Delolme F; Vianey-Saban C; Guffon N; Favre-Bonvin J; Guibaud P; Becchi M; Mathieu M; Divry P
    Arch Pediatr; 1997 Sep; 4(9):819-26. PubMed ID: 9345561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
    Purevsuren J; Kobayashi H; Hasegawa Y; Yamada K; Takahashi T; Takayanagi M; Fukao T; Fukuda S; Yamaguchi S
    Anal Bioanal Chem; 2013 Feb; 405(4):1345-51. PubMed ID: 23143007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation.
    Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM
    Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
    Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
    Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
    [No Abstract]   [Full Text] [Related]  

  • 18. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.
    Browning MF; Larson C; Strauss A; Marsden DL
    J Inherit Metab Dis; 2005; 28(4):545-50. PubMed ID: 15902557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience.
    Roe CR; Brunengraber H
    Mol Genet Metab; 2015 Dec; 116(4):260-8. PubMed ID: 26547562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.